Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Stoke Therapeutics (STOK)

:STOK

US Market

STOK

Stoke Therapeutics

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Stoke Therapeutics (STOK) Stock News & Sentiment

394 Followers

Buy Rating for Stoke Therapeutics: Promising Dravet Syndrome Treatment Shows Significant Improvements

Ratings

Buy Rating for Stoke Therapeutics: Promising Dravet Syndrome Treatment Shows Significant Improvements

4d ago

Positive Outlook on Stoke Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial for Dravet Syndrome Treatment

Ratings

Positive Outlook on Stoke Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial for Dravet Syndrome Treatment

14d ago

Stoke Therapeutics Advances Phase 3 Study for Dravet Syndrome Treatment

Company Announcements

Stoke Therapeutics Advances Phase 3 Study for Dravet Syndrome Treatment

18d ago

Stoke Therapeutics Adopts Key Proposals at Annual Meeting

Company Announcements

Stoke Therapeutics Adopts Key Proposals at Annual Meeting

1M ago

Stoke Therapeutics Launches Phase 3 EMPEROR Study

Company Announcements

Stoke Therapeutics Launches Phase 3 EMPEROR Study

1M ago

Promising Outlook for Stoke Therapeutics: Buy Rating Backed by Phase 3 Trial Progress and Strong Financial Position

Ratings

Promising Outlook for Stoke Therapeutics: Buy Rating Backed by Phase 3 Trial Progress and Strong Financial Position

2M ago

Stoke Therapeutics’ Zorevunersen: A Promising First-in-Class Therapy for Dravet Syndrome with Strong Commercial Potential

Ratings

Stoke Therapeutics’ Zorevunersen: A Promising First-in-Class Therapy for Dravet Syndrome with Strong Commercial Potential

2M ago

More STOK News >

STOK News on the Web

2025-05-16

Wall Street Analysts Think Stoke Therapeutics (STOK) Could Surge 132.4%: Read This Before Placing a Bet

Zacks

Bullish

2025-05-13

Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates

Zacks

Neutral

2025-05-12

Doximity Q4 Earnings Likely to Reflect Strong Product Momentum

Zacks

Neutral

2025-05-12

Why Stoke Therapeutics, Inc.’s (STOK) Stock Is Up 5.56%

AAII

Neutral

2025-05-09

Why Stoke Therapeutics, Inc.’s (STOK) Stock Is Up 5.03%

AAII

Neutral

2025-05-06

Why Stoke Therapeutics, Inc.’s (STOK) Stock Is Down 7.32%

AAII

Neutral

2025-05-01

BIIB's Q1 Earnings Miss, Revenues Top Mark, 2025 EPS Guidance Cut

Zacks

Bearish

2025-05-01

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

Neutral

News Score - Last 7 Days

Neutral

STOK

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week99%

Sector Average55%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is STOK’s Media Buzz Sentiment?

Currently, no data Available

What is STOK’s weekly average amount of articles?

Currently, no data Available

What is STOK’s News Sentiment?

99% of articles about STOK were positive this week, compared to its sector average of 55%.

Healthcare Stocks that are Trending in the News

RYTMRhythm Pharmaceuticals

ASTHAstrana Health

IDXXIdexx Laboratories

BKDBrookdale Senior Living

OTRKOntrak

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing